Contribution of proliferating leukocytes to phenotypic change in smooth muscle cells during the development of coronary arteriosclerosis in transplanted hearts

European Surgical Research

Volumn 32, Issue 1, 2000, Pages 30-38

  Shirasawa, B ^a   Hamano, Kimikazu ^a   Ueda, M ^b   Ito, H ^a   Kobayashi, T ^a   Fujimura, Y ^a   Kojima, A ^c   Esato, K ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Osaka Prefecture University   (Japan)

Author keywords

Arteriosclerosis; Coronary artery; Heart transplantation; Smooth muscle cell; Transplant rejection

Indexed keywords

ALPHA ACTIN; CYCLINE; CYCLOSPORIN A; MONOCLONAL ANTIBODY; VIMENTIN;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL DIFFERENTIATION; CORONARY ARTERY ATHEROSCLEROSIS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

EID: 0034098208     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008738     Document Type: Article

References (36)

1. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT: Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987;76:827-834.
2. Mohanakumar T, Rhodes C, Mendez-Picon G, Goldman M, Moncure C, Lee H: Renal allograft rejection associated with presensitization to HLA-DR antigens. Transplantation 1981; 31:93-95.
3. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH: Chronic rejection - an undefined conundrum. Transplantation 1991;52:389-398.
4. Adams DH, Russell ME, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ: Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model. Immunol Rev 1993;134:5-19.
5. Heemann UW, Tullius SG, Tamatami T, Miyasaka M, Milford E, Tilney NL: Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts. Transpl Int 1994;7:349-355.
6. Hancock WH, Whitley WD, Tullius SG, Heemann UW, Wasowska B, Baldwin WM, Tilney NL: Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993;56:643-650.
7. Demetris AJ, Zerbe T, Banner B: Morphology of solid organ allograft arteriopathy: Identification of proliferating intimal cell populations. Transplant Proc 1989;21:3667-3669.
8. Hamano K, Ito H, Ueki K, Fujimura Y, Tsuboi H, Esato K: Changes of coronary artery morphology and distribution of smooth muscle cells during progression of coronary atherosclerosis after heart transplantation. Int J Angiol 1995;4:69-73.
9. Häyry P, Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T: Rat aortic allografts: An experimental model for chronic transplant arteriosclerosis. Transplant Proc 1991;23:611-612.
10. Man YS, Ueda M, Tanabe S, Nakatani T, Kishimoto T, Suzuki S, Amemiya H: Immunocytochemical analysis of obliterative arteriopathy of human renal allografts. Transplant Proc 1994;26:931-934.
11. Tanabe S, Ueda M, Han YS, Nakatani T, Kishimoto T, Suzuki S, Amemiya H: Enhanced fibronectin expression is associated with the development of graft arteriosclerosis in human renal allografts. Transplant Proc 1995;27: 1078-1081.
12. Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 1990;96: 121-129.
13. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
14. Salom RN, Maguire JA, Esmore D, Hancock WW: Analysis of proliferating cell nuclear antigen expression aids histological diagnosis and is predictive of progression of human cardiac allograft rejection. Am J Pathol 1994;145:876-882.
15. Ono K, Lindsey ES: Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-229.
16. Gown AM, Vogel AM, Gordon D, Lu PL: A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol 1985;100:807-813.
17. Gown AM, Tsukada T, Ross R: Human atherosclerosis: Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125:191-207.
18. Tsukada T, Tippens D, Gordon D, Ross R, Gown AM: HHF35, a muscle-actin-specific monoclonal antibody: I. Immunocytochemical and biochemical characterization. Am J Pathol 1987;126:51-60.
19. Tsukada T, McNutt MA, Ross R, Gown AM: HHF35, a muscle-actin-specific monoclonal antibody: II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol 1987;127:389-402.
20. Gown AM, Vogel AM: Monoclonal antibodies to human intermediate filament proteins: Distribution of filament proteins in normal human tissues. Am J Pathol 1984;114:309-321.
21. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985;54:589-599.
22. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T: Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 1991;83:1327-1332.
23. Ueda M, Becker AE, Naruko T, Kojima A: Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis 1995;6: 71-81.
24. Takagi M, Ueda M, Becker AE, Takeuchi K, Takeda T: The Watanabe heritable hyperlipidemic rabbit is a suitable experimental model to study differences in tissue response between intimal and medial injury after balloon angioplasty. Arterioseler Thromb Vase Biol 1997;17: 3611-3619.
25. Hsu SM, Soban E: Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 1982; 30:1079-1082.
26. Gordon D, Reidy MA, Benditt EP, Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4604.
27. Rekhter MD, Gordon D: Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol 1995;147:668-677.
28. Wang J, Wang S, Lu Y, Weng Y, Gown AM: GM-CSF and M-CSF expression is associated with macrophage proliferation in progressing and regressing rabbit atheromatous lesions. Exp Mol Pathol 1994;61:109-118.
29. Rosenfeld ME, Pestel E: Cellularity of atherosclerotic lesions. Coron Artery Dis 1994;5: 189-197.
30. Campbell JH, Kaleviteh SG, Rennick RE, Campbell GR: Extracellular matrix-smooth muscle phenotype modulation by macrophages. Ann NY Acad Sci 1990;598:159-166.
31. Campbell JH, Campbell GR: The macrophage as an initiator of atherosclerosis. Clin Exp Pharmacol Physiol 1991;18:81-84.
32. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-3897.
33. Geng Y, Holm J, Nygren S, Bruzelius M, Stemme S, Hansson GK: Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vase Biol 1995;15:1995-2002.
34. Fuster V, Badimon L, Badimon J, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;250:310-318.
35. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995;92:402-406.
36. Ueda M, Becker AE, Kasayuki N, Kojima A, Morita Y, Tanaka S: In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol 1996;149:831-843.